Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:virus
|
| gptkbp:cause |
gptkb:poliomyelitis
|
| gptkbp:challenges |
gptkb:virus
global cooperation vaccine hesitancy access to vaccines surveillance improvements |
| gptkbp:community_health |
surveillance
vaccination campaigns outbreak response |
| gptkbp:controls |
case management
public education immunization hygiene practices travel restrictions |
| gptkbp:diagnosis |
laboratory testing
|
| gptkbp:diseases |
Sabin strain
attenuated strains |
| gptkbp:eradication_efforts |
gptkb:Global_Polio_Eradication_Initiative
|
| gptkbp:genetic_diversity |
high
|
| gptkbp:genetic_studies |
low
|
| gptkbp:geographic_distribution |
gptkb:Africa
gptkb:Europe gptkb:Middle_East gptkb:Asia |
| gptkbp:historical_significance |
eradication milestones
major epidemics |
| https://www.w3.org/2000/01/rdf-schema#label |
wild poliovirus strains
|
| gptkbp:impact |
gptkb:Health_Insurance
community awareness global health initiatives healthcare systems economic burden |
| gptkbp:is_affected_by |
gptkb:children
unvaccinated individuals |
| gptkbp:is_vulnerable_to |
gptkb:inactivated_polio_vaccine
oral polio vaccine |
| gptkbp:research_focus |
genetic studies
epidemiology vaccine development treatment options |
| gptkbp:scientific_classification |
wild type
|
| gptkbp:survivors |
environmental persistence
|
| gptkbp:symptoms |
fatigue
headache nausea fever sore throat muscle weakness paralysis |
| gptkbp:transmission |
fecal-oral route
|
| gptkbp:treatment |
supportive care
|
| gptkbp:type |
type 1
type 2 type 3 |
| gptkbp:bfsParent |
gptkb:inactivated_poliovirus
|
| gptkbp:bfsLayer |
7
|